eniluracil
Term · Oncology and biomedicine · MLC-T-ONC-002849
An anticancer drug that increases the effectiveness of fluorouracil. Also called ethynyluracil.
An orally-active fluoropyrimidine analogue. Eniluracil inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil (5-FU) in the liver. Co-administration of ethynyluracil permits the oral administration of 5-FU.
| Identifier | MLC-T-ONC-002849 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ethynyluracil; 5-ethynyluracil |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-002849",
"term": "eniluracil",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that increases the effectiveness of fluorouracil. Also called ethynyluracil.",
"An orally-active fluoropyrimidine analogue. Eniluracil inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil (5-FU) in the liver. Co-administration of ethynyluracil permits the oral administration of 5-FU."
],
"synonyms": [
"ethynyluracil",
"5-ethynyluracil"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/eniluracil/"
}
Record 6,693 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.